CPT1A and esophageal squamous cell carcinoma: STING suppresses ESCC progression by promoting CPT1A degradation and inhibiting FAO, and STING is downregulated in ESCC, suggesting that STING is a therapeutic target and prognostic marker for ESCC (Zhang et al., 2025).